Bridging micro/nano-platform and airway allergy intervention
Authors:
- 1 January 2022
- journal article
- review article
- Published by Elsevier in Journal of Controlled Release
- Vol. 341, 364-382
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31500807)
This publication has 213 references indexed in Scilit:
- IgE and mast cells in allergic diseaseNature Medicine, 2012
- Cancer immunotherapy via dendritic cellsNature Reviews Cancer, 2012
- Poly(lactide- co -glycolide) porous scaffolds for tissue engineering and regenerative medicineInterface Focus, 2012
- Proteinases as molecular adjuvants in allergic airway diseaseBiochimica et Biophysica Acta (BBA) - General Subjects, 2011
- IL‐28A (IFN‐λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway diseaseEMBO Molecular Medicine, 2011
- Promoting tolerance to proteolipid protein-induced experimental autoimmune encephalomyelitis through targeting dendritic cellsProceedings of the National Academy of Sciences, 2010
- Spatio-temporal localization of vasoactive intestinal peptide and neutral endopeptidase in allergic murine lungsRegulatory Peptides, 2010
- Swellable microparticles as carriers for sustained pulmonary drug deliveryJournal of Pharmaceutical Sciences, 2010
- Nanodelivery in airway diseases: Challenges and therapeutic applicationsNanomedicine: Nanotechnology, Biology and Medicine, 2010
- Asthma and Allergic InflammationCell, 2010